- Home
- BNT vs SNN Comparison
BNT vs SNN Comparison
Compare BNT & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BNT | SNN |
|---|---|---|
| Founded | 2020 | 1856 |
| Country | Bermuda | United Kingdom |
| Employees | 4000 | 16988 |
| Industry | | Industrial Specialties |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4B | 14.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BNT | SNN |
|---|---|---|
| Price | $45.48 | $32.02 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $36.25 |
| AVG Volume (30 Days) | 25.2K | ★ 900.0K |
| Earning Date | 05-08-2026 | 03-16-2026 |
| Dividend Yield | 0.62% | ★ 2.38% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.58 |
| Revenue Next Year | N/A | $5.60 |
| P/E Ratio | ★ $19.14 | $64.97 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $40.06 | $26.58 |
| 52 Week High | $74.16 | $38.79 |
Technical Indicators
Market Signals| Indicator | BNT | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 54.30 | 41.55 |
| Support Level | $44.62 | N/A |
| Resistance Level | $47.92 | $32.61 |
| Average True Range (ATR) | 1.09 | 0.56 |
| MACD | 0.11 | -0.14 |
| Stochastic Oscillator | 48.23 | 22.25 |
Price Performance
Historical ComparisonAbout BNT Brookfield Wealth Solutions Ltd.
Brookfield Wealth Solutions Ltd, formerly Brookfield Reinsurance Ltd operates a capital solutions business providing insurance and reinsurance services to individuals and institutions. Through its subsidiary, the company offers a broad range of insurance products and services, including life insurance and annuities, and personal and commercial property and casualty insurance. The Company's reporting segments are Annuities, P&C, Life Insurance and Corporate and Other. Majority revenue is generated from Annuities segment followed by P&C.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.